David Fazzolare is a biotech, pharma and medical device patent attorney in the Intellectual Property practice of Morse, Barnes-Brown & Pendleton. David’s practice centers on preparing and prosecuting patent applications, developing and managing patent portfolios, and counseling clients (e.g., universities, research institutions, mulitnational biopharmaceutical companies, medical device companies, startups, etc.) on patentability, infringement, and freedom-to-operate during all phases of a product’s lifecycle, from concept to commercialization.
David’s patent experience covers a variety of complex and innovative inventions involving small molecule drugs, biologics, cell-based technologies (e.g., stem cells, reprogramming, differentiation, regenerative medicine, etc.), nutritional supplements, compositions of matter, medical devices (e.g., catheters, stents, grafts, etc.), drug delivery devices and formulations, nucleic acid- and protein-based technologies (e.g., gene, peptide, antibody, and RNA therapeutics (e.g., antisense, siRNA, miRNA, mRNA, etc.), mutant proteins, genome editing, etc.) and diagnostic tests. David also has experience counseling clients on the Hatch-Waxman Act and is closely following developments involving biosimilars under the Biologics Price Competition and Innovation Act.
David’s technological experience spans fields as diverse as immunology, oncology, cardiology, neurology, genetics, cell biology, molecular biology, and indications such as diabetes, metabolic disorders, cancer, neurodegenerative disorders (e.g., motor neuron diseases, such as spinal muscular atrophy and amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer’s disease), and pain.
Prior to joining MBBP, David worked as a patent attorney and associate at Greenberg Traurig, LLP, and as a patent agent at Myriad Genetics, Inc. David received his J.D. cum laude from J. Reuben Clark Law School, and received his B.S. summa cum laude in Pharmacology from SUNY at Stony Brook. David received his M.S. cum laude in Biotechnology from Johns Hopkins University in May 2012.
Teaches an elective course, Intellectual Property and Patent Law for Researchers, for the online MS in Pharmacology and Toxicology at Michigan State University
SUNY at Stony Brook
J. Reuben Clark Law School
Johns Hopkins University